Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver

Journal of Virology

Volumn 81, Issue 9, 2007, Pages 4866-4871

  Stone, Daniel ^a   Liu, Ying ^a   Shayakhmetov, Dmitry ^a   Li, Zong Yi ^a   Ni, Shaoheng ^a   Lieber, André ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; LIVER SINUSOID; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SEROTYPE; SOUTHERN BLOTTING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BLOOD PLATELETS; GENE THERAPY; GENETIC VECTORS; LIVER; MICE; MICE, TRANSGENIC; RETICULOENDOTHELIAL SYSTEM;

ADENOVIRIDAE;

EID: 34247618144     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02819-06     Document Type: Article

References (51)

1. Alemany, R., K. Suzuki, and D. T. Curiel. 2000. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81:2605-2609.
2. Andrews, J. L., P. S. Shirley, W. O. Iverson, A. D. Sherer, J. E. Markovits, L. King, R. M. Lyons, M. Kaleko, and S. Connelly. 2002. Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector. Hum. Gene Ther. 13:1331-1336.
3. Bautista, M. J., E. Ruiz-Villamor, F. J. Salguero, P. J. Sanchez-Cordon, L. Carrasco, and J. C. Gomez-Villamandos. 2002. Early platelet aggregation as a cause of thrombocytopenia in classical swine fever. Vet. Pathol. 39:84-91.
4. Bernt, K. M., S. Ni, A. Gaggar, Z. Y. Li, D. M. Shayakhmetov, and A. Lieber. 2003. The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors. Mol. Ther. 8:746-755.
5. Castillo Salinas, F., C. Rodriguez Galindo, J. Iglesias Berengue, and I. Calico Bosch. 1991. Disseminated adenovirus infection associated with deep venous thrombosis in a previously healthy female infant. An. Esp. Pediatr. 34:163-164. (In Spanish.)
6. Cichon, G., S. Boeckh-Herwig, D. Kuemin, C. Hoffmann, H. H. Schmidt, E. Wehnes, W. Haensch, U. Schneider, U. Eckhardt, R. Burger, and P. Pring-Akerblom. 2003. Titer determination of Ad5 in blood: a cautionary note. Gene Ther. 10:1012-1017.
7. Cichon, G., H. H. Schmidt, T. Benhidjeb, P. Loser, S. Ziemer, R. Haas, N. Grewe, F. Schnieders, J. Heeren, M. P. Manns, P. M. Schlag, and M. Strauss. 1999. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J. Gene Med. 1:360-371.
8. Corash, L. 2001. Inactivation of infectious pathogens in labile blood components: meeting the challenge. Transfus. Clin. Biol. 8:138-145.
9. Di Paolo, N., S. Ni, A. Gaggar, R. Strauss, S. Tuve, Z.-Y. Li, D. Stone, D. Shayakhmetov, N. Kiviat, P. Touré, S. Sow, and A. Lieber. 2006. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting. Cancer Gene Ther. 13:1072-1081.
10. Eggerman, T. L., T. H. Mondoro, J. N. Lozier, and J. G. Vostal. 2002. Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum. Gene Ther. 13:125-128.
11. Endo, Y., M. Nakamura, Y. Nitta, and K. Kumagai. 1995. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. Br. J. Pharmacol. 114: 187-193.
12. Fassas, A. B., L. N. Buddharaju, A. Rapoport, M. Cottler-Fox, C. Drachen berg, B. Meisenberg, and G. Tricot. 2001. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after all-geneic bone marrow transplantation. Leuk. Lymphoma 42:801-804.
13. Gallo-Penn, A. M., P. S. Shirley, J. L. Andrews, S. Tinlin, S. Webster, C. Cameron, C. Hough, C. Notley, D. Lillicrap, M. Kaleko, and S. Connelly. 2001. Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. Blood 97:107-113.
14. Gawaz, M., H. Langer, and A. E. May. 2005. Platelets in inflammation and atherogenesis. J. Clin. Investig. 115:3378-3384.
15. Heim, A., C. Ebnet, G. Harste, and P. Pring-Akerblom. 2003. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70:228-239.
16. Heyns Adu, P., P. N. Badenhorst, M. G. Letter, H. Pieters, P. Wessels, and H. F. Kotze. 1986. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood 67:86-92.
17. Higginbotham, J. N., P. Seth, R. M. Blaese, and W. J. Ramsey. 2002. The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum. Gene Ther. 13:129-141.
18. Jiang, H., Z. Wang, D. Serra, M. M. Frank, and A. Amalfitano. 2004. Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies. Mol. Ther. 10:1140-1142.
19. Levi, M., T. T. Keller, E. van Gorp, and H. ten Cate. 2003. Infection and inflammation and the coagulation system. Cardiovasc. Res. 60:26-39.
20. Lieber, A., C. Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
21. Liu, Q., A. K. Zaiss, P. Colarusso, K. Patel, G. Haljan, T. J. Wickham, and D. A. Muruve. 2003. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 14:627-643.
22. Lozier, J. N., G. Csako, T. H. Mondoro, D. M. Krizek, M. E. Metzger, R. Costello, J. G. Vestal, M. E. Rick, R. E. Donahue, and R. A. Morgan. 2002. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum. Gene Ther. 13:113-124.
23. Luk, S. C., E. Musclow, and G. T. Simon. 1980. Platelet phagocytosis in the spleen of patients with idiopathic thrombocytopenic purpura (ITP). Histopathology 4:127-136.
24. Lyons, M., D. Onion, N. K. Green, K. Asian, R. Rajaratnam, M. Bazan-Peregrino, S. Phipps, S. Hale, V. Mautner, L. W. Seymour, and K. D. Fisher. 2006. Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol. Ther. 14:118-128.
25. Manickan, E., J. S. Smith, J. Tian, T. L. Eggerman, J. N. Lozier, J. Muller, and A. P. Byrnes. 2006. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol. Ther. 13:108-117.
26. Morral, N., W. K. O'Neal, K. Rice, M. M. Leland, P. A. Piedra, E. Aguilar-Cordova, K. D. Carey, A. L. Beaudet, and C. Langston. 2002. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene Ther. 13:143-154.
27. Mrkic, B., J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
28. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15:1157-1166.
29. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
30. Musaji, A., F. Cormont, G. Thirion, C. L. Cambiaso, and J. P. Coutelier. 2004. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses. Blood 104:2102-2106.
31. Neiman, J. C., M. J. Mant, and T. K. Shnitka. 1987. Phagocytosis of platelets by Kupffer cells in immune thrombocytopenia. Arch. Pathol. Lab. Med. 111:563-565.
32. Nieswandt, B., B. Echtenacher, F. P. Wachs, J. Schroder, J. E. Gessner, R. E. Schmidt, G. E. Grau, and D. N. Mannel. 1999. Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice. Blood 94:684-693.
33. Othman, M., A. Labelle, I. Mazzetti, H. S. Elbatarny, and D. Lillicrap. 5 December 2006. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood. doi:10.1182/blood-2006-06-032524.
34. Parker, A. L., J. H. McVey, J. H. Doctor, O. Lopez-Franco, S. N. Wadding ton, M. Havenga, S. A. Nicklin, and A. H. Baker. 24 January 2007. Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J. Virol. doi:10.1128/JVI.02786-06.
35. Parker, A. L., S. N. Waddington, C. G. Nicol, D. M. Shayakhmetov, S. M. Buckley, L. Denby, G. Kemball-Cook, S. Ni, A. Lieber, J. H. McVey, S. A. Nicklin, and A. H. Baker. 2006. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108:2554-2561.
36. Rand, M. L., and J. F. Wright. 1998. Virus-associated idiopathic thrombocytopenic purpura. Transfus. Sci. 19:253-259.
37. Raper, S. E., M. Yudkoff, N. Chirmule, G. P. Gao, F. Nunes, Z. J. Haskal, E. E. Furth, K. J. Propert, M. B. Robinson, S. Magosin, H. Simoes, L. Speicher, J. Hughes, J. Tazelaar, N. A. Wivel, J. M. Wilson, and M. L. Batshaw. 2002. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. 13:163-175.
38. Schiedner, G., S. Hertel, M. Johnston, V. Dries, N. van Rooijen, and S. Kochanek. 2003. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol. Ther. 7:35-43.
39. Schnell, M. A., Y. Zhang, J. Tazelaar, G. P. Gao, Q. C. Yu, R. Qian, S. J. Chen, A. N. Varnavski, C. LeClair, S. E. Raper, and J. M. Wilson. 2001. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 3:708-722.
40. Shayakhmetov, D. M., A. Gaggar, S. Ni, Z. Y. Li, and A. Lieber. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79:7478-7491.
41. Shayakhmetov, D. M., Z. Y. Li, S. Ni, and A. Lieber. 2004. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78:5368-5381.
42. Shayakhmetov, D. M., Z. Y. Li, S. Ni, and A. Lieber. 2005. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors. J. Immunol. 174:7310-7319.
43. + cells by a retargeted adenovirus vector. J. Virol. 74:2567-2583.
44. Smith, T. A., N. Idamakanti, M. L. Rollence, J. Marshall-Neff, J. Kim, K. Mulgrew, G. R. Nemerow, M. Kaleko, and S. C. Stevenson. 2003. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum. Gene Ther. 14:777-787.
45. Stone, D., S. Ni, Z. Y. Li, A. Gaggar, N. DiPaolo, Q. Feng, V. Sandig, and A. Lieber. 2005. Development and assessment of human adenovirus type 11 as a gene transfer vector. J. Virol. 79:5090-5104.
46. Tao, N., G. P. Gao, M. Parr, J. Johnston, T. Baradet, J. M. Wilson, J. Barsoum, and S. E. Fawell. 2001. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol. Ther. 3:28-35.
47. Varnavski, A. N., R. Calcedo, M. Bove, G. Gao, and J. M. Wilson. 2005. Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice. Gene Ther. 12:427-436.
48. Vrancken Peeters, M. J., A. L. Perkins, and M. A. Kay. 1996. Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques 20:278-285.
49. Wolff, G., S. Worgall, N. van Rooijen, W. R. Song, B. G. Harvey, and R. G. Crystal. 1997. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71:624-629.
50. Wolins, N., J. Lozier, T. L. Eggerman, E. Jones, E. Aguilar-Cordova, and J. G. Vestal. 2003. Intravenous administration of replication- incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br. J. Haematol. 123:903-905.
51. Worgall, S., G. Wolff, E. Falck-Pedersen, and R. G. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37-44.